Visugromab Biosimilar(Anti-GDF15 / MIC1 Reference Antibody) Datasheet DC Chemicals
Description
Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors.